Parkinson's Disease Research

Parkinson's disease (PD) is a degenerative disease of the central nervous system that often impairs motor skills, speech, and other functions. Symptoms of the disease include resting tremor, bradykinesia and rigidity. The primary symptoms are the result of decreased stimulation of the motor cortex by the basal ganglia, normally caused by the insufficient formation and action of dopamine, which is produced in the dopaminergic neurons of the brain. Symptoms of the disease appear once 50-80% of dopamine neurons have died. Parkinson's disease is both chronic and progressive.

Parkinson's Disease Research Products Targets

Products for Parkinson's Disease Research - Page 48

  1. Cat.No. Product Name Information/Activity
  2. BCC6107 Flunitrazepam 1622-62-4 Flunitrazepam chemical structure
  3. BCN6250 Hispidulin Hispidulin is a natural flavone with a broad spectrum of biological activities. Hispidulin is a Pim-1 inhibitor with an IC50 of 2.71 μM. Hispidulin chemical structure
  4. BCC5970 Lorazepam 846-49-1 Lorazepam chemical structure
  5. BCC6745 PK 11195 PK 11195 (RP 52028) is a ligand of translocator protein (TSPO), which targets Leishmania chemotherapy, with IC50s of 14.2 μM, 8.2 μM, 3.5 μM for L. amazonensis, L. major and L. braziliensis, respectively. PK 11195 chemical structure
  6. BCC7230 Ro 15-4513 Ro15-4513, imidazobenzodiazepinone derivative, is a partial inverse agonist of benzodiazepine receptor (BZR). Ro15-4513 is a potent ethanol antagonist. Ro15-4513 has anti-anxiety effect. Ro 15-4513 chemical structure
  7. BCC7228 Ro 19-4603 99632-94-7 Ro 19-4603 chemical structure
  8. BCC6087 TCS 1105 185391-33-7 TCS 1105 chemical structure
  9. BCC5197 Zaleplon 151319-34-5 Zaleplon chemical structure
  10. BCC7227 ZK 93423 hydrochloride Potent benzodiazepine agonist ZK 93423 hydrochloride chemical structure
  11. BCC7229 ZK 93426 hydrochloride 1216792-30-1 ZK 93426 hydrochloride chemical structure

Items 471 to 480 of 752 total